Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience-Reference-Cited by-同舟云学术

Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience

Published:2018-04 Issue:4 Volume:68 Page:691-698
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Elsharkawy Aisha,El-Raziky Maissa,El-Akel Wafaa,El-Saeed Kadry,Eletreby Rasha,Hassany Mohamed,El-Sayed Manal Hamdy,Kabil Khaled,Ismail Sohier A.,El-Serafy Magdy,Abdelaziz Ashraf Omar,Shaker Mohamed Kamal,Yosry Ayman,Doss Wahid,El-Shazly Yehia,Esmat Gamal,Waked Imam

Publisher

Elsevier BV

Subject

Hepatology

Reference33 articles.

1. Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies;Estes;Aliment Pharmacol Ther,2015

2. The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment;Kandeel;Liver Int,2017

3. Global epidemiology and genotype distribution of the hepatitis C virus;Gower;J Hepatol,2014

4. Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis;Riou;J Viral Hepat,2016

5. Sofosbuvir for previously untreated chronic hepatitis C infection;Lawitz;N Engl J Med,2013

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C infection;Treatment and Management of Tropical Liver Disease;2025

2. Hepatitis C Elimination in Egypt: Story of Success;Pathogens;2024-08-12

3. The Egyptian journey from having the highest prevalence of hepatitis C virus to being the first to achieve “gold tier” in conquering the disease;Baylor University Medical Center Proceedings;2024-07-22

4. Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial);Scientific Reports;2024-05-03

5. Diabetic patients with chronic hepatitis C virus response compared to non diabetics when treated with directly acting antiviral therapy;Arab Journal of Gastroenterology;2024-05